This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Reveley, M.A. Articles by Andrews, H. Search for Related Content PubMed Articles by Reveley, M.A. Articles by Andrews, H. Social Bookmarking                         What's this?

A comparative trial use of sulpiride and risperidone in Huntington's disease: a pilot study

Department of Psychiatry, Robert Kilpatrick Clinical Sciences Building, Faculty of Medicine, University of Leicester, Leicester LE2 7LX, UK

S.M. Dursun

Department of Psychiatry, Robert Kilpatrick Clinical Sciences Building, Faculty of Medicine, University of Leicester, Leicester LE2 7LX, UK

H. Andrews

Department of Psychiatry, Robert Kilpatrick Clinical Sciences Building, Faculty of Medicine, University of Leicester, Leicester LE2 7LX, UK

Sulpiride and risperidone treatment significantly improved the abnormal involuntary movements of two patients with Huntington's disease on both actometer and clinical assessments. However, treatment with risperidone, but not sulpiride, significantly improved the functional activities as assessed by the Functional Disability Scale. To the best of our knowledge this is the first report of the successful treatment of Huntington's disease with risperidone.

Key Words: Huntington's disease • risperidone • sulpiride • actometer • AIMs • functional disability • case report

Journal of Psychopharmacology, Vol. 10, No. 2, 162-165 (1996)
DOI: 10.1177/026988119601000213


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?